MENU

Supply Chain Intelligence about:

Lupin Group

Company profile   India

See Lupin Group's products and customers

Thousands of companies like you use Panjiva to research suppliers and competitors.

Easy access to trade data

Cleaned and organized South American shipments

5 South American shipments available for Lupin Group
Date Data Source Customer Details
2020-12-30 Ecuador Imports
INDEUREC S.A.
Shipment data shows what products a company is trading and more. Learn more

Explore trading relationships hidden in supply chain data

Contact information for Lupin Group

 
Address
MA
 
 

Sample Bill of Lading

969 shipment records available

Bill of Lading Number
CEC2020PCIU0016
Departure Date
2020-12-30
Arrival Date
2020-12-30
Consignee
Indeurec S.A.
Consignee (Original Format)
INDEUREC S.A., GUAYAS
Consignee Number
0991254374001
Shipper
Lupin Group
Shipper (Original Format)
LUPIN LIMITED
Carrier
COSU - Cosco Shipping Lines Co Ltd
Notify Party
INDEUREC S.A.
Shipment Origin
India
Shipment Origin (Original Format)
INDIA
Shipment Destination
GUAYAQUIL
Port of Origin
JAWAHARLAL NEHRU (NHAVA SHEVA)
Port of Unlading
Guayaquil (EC)
Port of Lading
Hong Kong (HK)
Vessel
KOTA CEPAT
Vessel (Original Format)
SG
Volume (TEU)
0.0
Item Quantity
1.0
Item Unit
PALETAS (PALLETES O PARIHUELAS)
Gross Weight (kg)
244.52
Container Type
LCL
Container Numbers
BMOU9277019
Container Number 20
0.0
Container Number 40
0.0
Agent Name
AGENCIA DEL PACIFICO DELPAC S.A.

Recent Panjiva Research about Lupin Group

20161223-statins-total

Statins Not Static, Reddy’s Ready to Win

U.S. imports of statins, used to primarily to manage cholesterol, increased 14% in November on a year earlier. Crestor and its generic versions jumped 480% on a year earlier after the end of its patent in April. It took market share from generic Pravachol, which saw imports fall 35% to their l... Read more →

20161121-statins-total

Statin Imports Accelerate After Crestor Passes Its Crest

U.S. imports of the anti-cholesterol drugs known as statins increased 40% in October on a year earlier. This was their fastest growth since January and the highest level of imports for the month since at least 2007. This was driven by generic versions of AstraZeneca’s Crestor being available s... Read more →